About clonoSEQ
A test that’s as powerful as today’s cancer treatments
clonoSEQ is a blood or bone marrow test1 that measures your cancer at the deepest level currently available,1-3 helping your doctor make more informed decisions about your care. It is FDA-cleared in bone marrow and CLIA-validated in peripheral blood for multiple myeloma.
About clonoSEQ
A test that’s as powerful as today’s cancer treatments
clonoSEQ is a blood or bone marrow test1 that measures your cancer at the deepest level currently available,1-3 helping your doctor make more informed decisions about your care. It is FDA-cleared in bone marrow and CLIA-validated in peripheral blood for multiple myeloma.
clonoSEQ helps your doctor tailor treatment to your needs
clonoSEQ uses next-generation sequencing technology, an advanced testing method that decodes your cancer’s genetic information, to look for unique cancer DNA sequences
that serve as “barcodes.” After your diagnosis, clonoSEQ identifies and counts your
cancer’s unique “barcodes.” During treatment and remission, clonoSEQ can tell you and
your doctor if and how the number of “barcodes” has changed since your last MRD test.1
clonoSEQ is covered by Medicare and other major insurance providers